eRx Router ETASU Enforcement via Encrypted RDA Validation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Risk Evaluation and Mitigation Strategies (REMS) systems, particularly those requiring Elements to Assure Safe Use (ETASU), face challenges in timely and accurate enforcement, often causing confusion, rework, and inconvenience by implementing Hard Stops late in the patient care process, which can affect drug access and complicate insurance and safety reasons.
Innovation Solution
An e-prescription (eRx) based ETASU enforcement model that incorporates an encrypted REMS Dispense Authorization (RDA) into electronic prescriptions, allowing an eRx router to validate ETASU compliance before passing validated prescriptions to pharmacies, reducing manual intervention and ensuring compliance upfront in the patient care process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Hard Stop enforcement is implemented at the pharmacy level during dispensing, then compliance with ETASU can be enforced, but it causes confusion, rework, and inconvenience to patients and stakeholders
Solution Approach 1:
The patent implements ETASU compliance verification at the e-prescription routing stage before the prescription reaches the pharmacy. The system validates whether required ETASU actions have been completed by checking for associated records in the database, thereby performing the compliance check in advance rather than at the point of dispensing. This preliminary action prevents compliance issues from causing disruptions later in the patient care process.
2Reliability
If manual verification of ETASU compliance is required at the pharmacy, then compliance can be checked, but it increases burden on pharmacists and reduces productivity
Solution Approach 1:
The system performs automatic verification of ETASU compliance through electronic record checking. When an e-prescription is routed, the system automatically queries the database to determine whether required ETASU actions have been completed, eliminating the need for pharmacists to manually verify compliance. This automated self-service approach maintains reliable compliance verification while preserving pharmacy productivity.
Solution Approach 2:
The patent replaces manual mechanical verification processes with automated electronic validation. Instead of pharmacists physically checking compliance documentation or contacting external systems, the e-prescription routing system electronically validates ETASU status through automated database queries, substituting human effort with automated information processing.
3Ease of manufacture
If ETASU compliance is not verified before prescription filling, then the process is simpler, but it leads to rejected prescriptions and loss of time
Solution Approach 1:
The system performs ETASU compliance verification as a preliminary step during e-prescription routing, before the prescription reaches the pharmacy for filling. This advance validation ensures that compliance requirements are met before the prescription enters the fulfillment process, preventing later rejections and avoiding time losses associated with correcting non-compliant prescriptions.
4Measurement precision
If encrypted RDA is incorporated into e-prescriptions, then compliance accuracy is improved, but system complexity increases
Solution Approach 1:
The patent introduces an e-prescription routing system as an intermediary between prescribers and pharmacies. This routing system handles the complexity of encrypted RDA verification, database queries for ETASU status, and compliance validation logic. By concentrating the complex verification functions in a centralized routing intermediary rather than distributing complexity across multiple systems, the solution achieves high compliance validation accuracy while managing system complexity centrally.
Data Source
AI summary
Utilizing electronic prescriptions (eRx), ETASU enforcement for a drug associated with a REMS may be performed at a more natural point in prescription processing. By incorporating an encrypted REMS Dispense Authorization (RDA) into eRxs, an eRx router may validate various elements of the eRx against encrypted data elements and thereby verify that any ETASUs required by a REMS for a prescribed drug have been complied with. As a result, only validated eRx are passed from the eRx router to pharmacies for dispensing, reducing manual intervention to confirm compliance. Information necessary to perform validation may be communicated to the eRx router by a Trusted Central RDA Authority (TCRA), and may include decryption keys, prescriber authorization data, and appropriate validation check algorithms.